Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1344
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAKTU-
dc.date.accessioned2025-09-30T09:51:59Z-
dc.date.available2025-09-30T09:51:59Z-
dc.date.issued2024-06-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/1344-
dc.language.isoen_USen_US
dc.publisherAKTUen_US
dc.subjectpreformulation (physicochemical properties, polymorphism, BCS classification), solid dosage forms (tablets, capsules), liquid oral dosage forms (syrups, suspensions, emulsions), parenteral productsen_US
dc.titleBP502T INDUSTRIAL PHARMACY I THEORYen_US
dc.typeOtheren_US
Appears in Collections:2023-2024

Files in This Item:
File Description SizeFormat 
BP502T INDUSTRIAL PHARMACY I THEORY.pdf118.34 kBAdobe PDFDownload


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.